Loading...
OTCM
CLABF
Market cap3mUSD
Jul 08, Last price  
0.05USD
1D
0.00%
1Q
21.38%
IPO
-99.44%
Name

Core One Labs Inc

Chart & Performance

D1W1MN
P/E
P/S
6.56
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
142.58%
Revenues
648k
+50.15%
000058,29856,086191,1264,080,7475,041,6510431,616648,088
Net income
-16m
L-56.88%
-260,215-459,229-441,800-428,103-1,206,673-2,866,344-12,596,268-12,286,877-21,463,191-54,618,982-37,054,907-15,976,360
CFO
-2m
L-56.99%
-155,257-303,291-294,219-49,312-1,010,492-1,492,779-5,205,336-10,157,006-5,772,029-2,324,611-4,642,100-1,996,522

Profile

Core One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
IPO date
Aug 17, 2011
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
648
50.15%
Cost of revenue
8,516
Unusual Expense (Income)
NOPBT
(7,868)
NOPBT Margin
Operating Taxes
5
Tax Rate
NOPAT
(7,874)
Net income
(15,976)
-56.88%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,260
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
(1,997)
CAPEX
(13)
Cash from investing activities
190
Cash from financing activities
2,610
FCF
(9,828)
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
30,751
Price
Market cap
EV
EBITDA
(7,817)
EV/EBITDA
Interest
5
Interest/NOPBT